Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers

Status Recruiting

Clinical Trial Summary

To evaluate the safety and tolerability of single subcutaneous injection of Genakumab for Injection in Chinese healthy adult volunteers

Clinical Trial Description

There are 5 dose groups with 8 participants in each group, including 6 participants in the experimental group and 2 participants in the placebo control group.

Since the strength of experimental drug is 150mg/1ml/ bottle, participants with a single dose of more than 150mg need to be given subcutaneously at different sites in two or more times ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04337437
Study type	Interventional
Source	GeneScience Pharmaceuticals Co., Ltd.
Contact	Luocheng Xu
Phone	800-820-0469
Email	xuluocheng@gensci-china.com
Status	Recruiting
Phase	Phase 1
Start date	April 22, 2019
Completion date	September 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02776735` - An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)	Phase 2
Active, not recruiting	`NCT03092427` - Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)	N/A
Not yet recruiting	`NCT05545098` - MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
Not yet recruiting	`NCT03833609` - Yoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis	N/A
Completed	`NCT02524340` - Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
Recruiting	`NCT01434082` - Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis	N/A
Completed	`NCT04671524` - The Effect of Improvement in Function on Foot Pressure, Balance and Gait in Children With Upper Extremity Affected	N/A
Recruiting	`NCT04167488` - Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy	N/A
Recruiting	`NCT04205500` - Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis	N/A
Terminated	`NCT01694264` - Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα	Phase 3
Completed	`NCT02824978` - Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
Active, not recruiting	`NCT03841357` - Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)	Phase 3
Completed	`NCT03833271` - The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary	Early Phase 1
Completed	`NCT01455701` - A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)	Phase 1
Completed	`NCT05031104` - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis	N/A
Not yet recruiting	`NCT01436019` - Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis	N/A
Recruiting	`NCT05609630` - Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3
Recruiting	`NCT05696340` - Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
Recruiting	`NCT05545839` - Transition to Adulthood Through Coaching and Empowerment in Rheumatology	N/A
Completed	`NCT05436301` - Turkish Validity and Reliability of Pain Catastrophizing Scale-Child (PCS-C)